Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
Home BestProtocols® Technical Support About Us Contact Us
Clinical Products Research Products Custom Products Weekly New Products

Choose language for TDS:
 

Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Biotin

Also known as: GL-7, Ly-77, Ly77

RUO: For Research Use Only
mouse GL7 antibody, Biotin conjugatemouse GL7 antibody, Biotin conjugateStaining of 3-day unstimulated (left) and 3-day ConA activated (right) BALB/c splenocytes with 0.5 µg of Rat IgM Isotype Control Biotin (cat. 13-4341) (open histogram) or 0.25µg of Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Biotin (filled histogram) followed by Streptavidin PE (cat. 12-4317). Total viable cells were used for analysis.
Contents: Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Biotin
Catalog Number: 13-5902
Concentration: 0.5 mg/ml
Formulation: Phosphate buffer pH 7.2,
500 mM NaCl, 0.09% NaN3
Storage Conditions: Store at 2-8°C. Do not freeze.
Clone: GL-7 (GL7)
Host/Isotype: Rat IgM
 
Product Options
Cat. No. Size Price Add Qty to Cart
13-5902-81 50 ug
To view relevant pricing, please select your country and resume browsing.

13-5902-82 100 ug
13-5902-85 500 ug
Note: Several countries will continue to be supplied via distributors. Country specific prices may apply.
 
Research Related Products
Cat. No.Format
11-4317 Streptavidin FITC
12-4317 Streptavidin PE
13-4341 Rat IgM Isotype Control Biotin
17-4317 Streptavidin APC
 

Available Formats
Cat. No.FormatExcite
(nm)
Emit
(nm)
Reported ApplicationsRegulatory Status
13-5902 Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Biotin N/A N/A FC RUO
14-5902 Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Purified N/A N/A FC IHC (F) IP RUO
51-5902 Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Alexa Fluor® 647 633 668 FC RUO
53-5902 Anti-Human/Mouse GL7 (T and B Cell Activation Marker) Alexa Fluor® 488 488 519 FC RUO
Flow Cytometry Product Notes:
Test Sizes: To accommodate multicolor flow cytometry, eBioscience is in the process of reducing test size volumes from 20 µl to 5 µl. Please check your antibody vial for the recommended test size.
Fluorochrome Replacements: eBioscience is in the process of replacing all Alexa Fluor® 647 conjugated products with eFluor® 660 conjugated products.
 
Description
This GL7 monoclonal antibody reacts with a cell-surface protein found on T and B lymphocytes activated in vitro, on bone marrow pre-B-II cells, germinal center B cells, and also human B cell lines Ramos and Daudi. There is strain variability with respect to antigen distribution on thymocytes and Con A-activated spleen cells, with expression in BALB/c greater than that in C57BL/6. GL7 is commonly used as a marker for mouse germinal center B cells. The epitope of GL7 has been identified as a sialic acid glycan moiety called Neu5Ac. This moiety is recognized by CD22.
Applications Reported
For research use only, not for diagnostic or therapeutic use.
Applications Tested
The GL-7 (GL7) antibody has been tested by flow cytometric analysis of ConA-activated mouse splenocytes. This can be used at less than or equal to 0.5 μg per test. A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 µL. Cell number should be determined empirically but can range from 105 to 108 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
References
Kimura N, Ohmori K, Miyazaki K, Izawa M, Matsuzaki Y, Yasuda Y, Takematsu H, Kozutsumi Y, Moriyama A, Kannagi R. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J Biol Chem. 2007 Nov 2;282(44):32200-7. (GL7, FA, human cells, PubMed)

Naito Y, Takematsu H, Koyama S, Miyake S, Yamamoto H, Fujinawa R, Sugai M, Okuno Y, Tsujimoto G, Yamaji T, Hashimoto Y, Itohara S, Kawasaki T, Suzuki A, Kozutsumi Y. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol. 2007 Apr;27(8):3008-22.

Laszlo, G., K.S. Hathcock, H.B. Dickler, and R.J. Hodes. 1993. Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells. J. Immunol. 150: 5252 - 5262.

Han, S., B. Zheng, D.G. Schatz, E. Spanopoulou, and G. Kelsoe. 1996. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 274: 2094 - 2097.

Han, S., B. Zheng, Y. Takahashi, and G. Kelsoe. 1997. Distinctive characteristics of germinal center B cells. Semin. Immunol. 9: 255 - 260.

Han, S., S.R. Dillon, B. Zheng, M. Shimoda, M.S. Schlissel, and G. Kelsoe. 1997. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science278: 301 - 305.

Hathcock, K.S., C.E.M. Pucillo, G. Laszlo, L. Lai, and R.J. Hodes. 1995. Analysis of thymic subpopulations expressing the activation antigen GL7. Expression, genetics, and function. J. Immunol. 155: 4575 - 4581.

Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2010 eBioscience, Inc.
Unless indicated otherwise, all products are For Research Use Only. Not for use in diagnostic or therapeutic procedures. Not for further distribution without written consent. Not all products available in all regions.